Startup with eye on fatty liver disease NASH lays out $70M IPO plan

The company started in January 2018 in Israel and moved to San Francisco this year.

Source: bizjournals.com Health Care:Biotechnology headlines - October 11, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news